Foamix Pharmaceuticals Ltd. | Key People and Executives
David Domzalski
Chief Executive Officer & Director
Darrell S. Rigel
Independent Director
Rex Bright
Independent Director
Stanley B. Stern
Independent Director
Anna Kazanchyan
Independent Director
David Domzalski
Chief Executive Officer & Director
Ilan Hadar
Chief Financial Officer & Country Manager
Iain Stuart
Senior Vice President-Research & Development
Yohan Hazot
Vice President-Pharmaceutical Development
Mitchell Shirvan
Vice President-Innovation & Discovery
David Schuz
Vice President-Intellectual Property
Mutya Harsch
Senior VP-Legal Affairs & General Counsel
Alvin D. Howard
Vice President-Regulatory Affairs
Darrell S. Rigel
Independent Director
Rex Bright
Independent Director
Stanley B. Stern
Independent Director
Anna Kazanchyan
Independent Director
| Address |
2 Holzman Street
Rehovot HM 76704
Israel
|
|
Employees
|
- |
| Website |
http://www.foamixpharma.com |
| Updated |
07/08/2019 |
| Foamix Pharmaceuticals Ltd. is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. |
